---
schema_version: "secwatch.filing_event.v1"
accession: "0001932393-24-000051"
form_type: "8-K"
ticker: "GEHC"
cik: "0001932393"
company_name: "GE HealthCare Technologies Inc."
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:36:06.344004+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# GE HealthCare realigns IGT to AVS segment; recasts 2022-2024 segment revenue and EBIT

## Summary
- Effective July 1, 2024, Image Guided Therapies moved from Imaging to Ultrasound, renamed Advanced Visualization Solutions (AVS).
- Recast Q2 2024 Imaging revenue $2,171M; AVS revenue $1,249M (Procedural Guidance $668M, Specialized Ultrasound $581M).
- Recast Q2 2024 Segment EBIT: Imaging $208M, AVS $255M, PCS $78M, PDx $200M.
- Total revenue and EBIT unchanged; company now reports four segments: Imaging, AVS, PCS, PDx.

## SEC filing metadata
- accession: 0001932393-24-000051
- form_type: 8-K
- ticker: GEHC
- cik: 0001932393
- company_name: GE HealthCare Technologies Inc.
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1932393/000193239324000051/0001932393-24-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1932393/000193239324000051/gehc-20241030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001932393-24-000051
- JSON: https://secwatch.observer/filing/0001932393-24-000051.json
- Plain text: https://secwatch.observer/filing/0001932393-24-000051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.